The search for the next James Bond is reportedly entering its final stages, with screen tests for the coveted role said to be taking place this week. Actors Jack Lowden and Callum Turner have been widely reported as being on the shortlist, with Deadline also indicating that Josh O'Connor is in contention.
A fourth actor is rumored to be part of the final selection, though their identity remains unconfirmed. The Hollywood Reporter has stated that Jack O'Connell is not among the finalists, while both Deadline and THR have clarified that Jacob Elordi, despite earlier speculation, is not testing for the part. The remaining candidates are expected to undergo evaluations for stunts, dialogue delivery, and on-camera presence.
This development suggests a potential announcement of the new James Bond could occur in November or December. The film is slated to be director Denis Villeneuve's next project following "Dune Part 3," though a release date has not yet been set. If production commences next year, a late 2028 release is possible. A script is reportedly already in place, with casting now being the primary focus.
Casting discussions for the new Bond have been ongoing since the spring, and numerous names have surfaced as potential candidates. While Lowden has garnered significant fan support, former Bond actor Daniel Craig previously expressed his support for O'Connor, even joking about having started rumors of his potential involvement. It now appears those rumors may have materialized.
The future direction of the James Bond franchise remains a subject of speculation. The grounded, serious tone of Daniel Craig's tenure would seemingly align with Villeneuve's directorial style. However, producers are reportedly not looking to revisit an origin story, as "Casino Royale" successfully explored that territory. Early reports had suggested a preference for a younger actor, but the three confirmed finalists are all 36 years old, only slightly younger than Craig was when he debuted as Bond. This could indicate a shift in direction or a different approach to the actor's longevity in the role, potentially moving away from the extended, injury-prone tenures of previous Bonds.